RxDoctor Payments DataLook up a doctor →

Tyler Hyslep, PA

Medical · Charlotte, NCNPI 1265822720

Payments from drug & device makers

$12,970in general payments, 2019–2025

Across 751 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$2K
  • Novo Nordisk$2K
  • Boehringer Ingelheim$765
  • Lilly USA, LLC$695
  • AstraZeneca$557
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)114$1,704
Pfizer84$1,528
Novo Nordisk94$1,509
Boehringer Ingelheim38$765
Lilly USA, LLC39$695
AstraZeneca31$557
Bayer32$534
Astellas Pharma US Inc27$513
Amgen(2 entities)34$476
Takeda Pharmaceuticals U.S.A., Inc.19$334
GSK15$289
Johnson & Johnson13$253
Bausch Health US, LLC14$224
Esperion Therapeutics, Inc.12$198
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$193
Abbott11$192
Sumitomo Pharma America, Inc.9$189
Axsome Therapeutics, Inc.8$161
Biohaven Pharmaceutical Holding Company Ltd.9$148
Merck8$136
Amneal Pharmaceuticals LLC7$133
Eisai Inc.7$121
Xeris Pharmaceuticals, Inc.7$120
Biohaven Pharmaceuticals, Inc.8$112
Amarin Pharma, Inc.5$101
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$97
Novartis5$95
Sanofi-aventis U.S. LLC4$86
Kowa Pharmaceuticals America, Inc.5$80
Jazz Pharmaceuticals Inc.5$79
Paratek Pharmaceuticals, Inc.5$78
IBSA Pharma Inc.5$75
Idorsia Pharmaceuticals US Inc4$73
Teva Pharmaceuticals USA, Inc.3$70
Neos Therapeutics, LP4$65
Insightec,inc1$63
Phathom Pharmaceuticals, Inc.4$63
Corcept Therapeutics3$60
Azurity Pharmaceuticals, Inc.3$60
Medtronic3$53
Tolmar, Inc.3$52
Arbor Pharmaceuticals, Inc.3$50
Clarus Therapeutics Inc.2$49
E.r. Squibb & Sons, L.L.C.3$42
Medicure Pharma Inc.1$40
Daiichi Sankyo Inc.2$38
Dexcom, Inc.2$37
Sunovion Pharmaceuticals Inc.2$35
Inspire Medical Systems, Inc.2$35
Shield Therapeutics Inc2$31
Otsuka America Pharmaceutical, Inc.1$29
Boston Scientific1$28
Mayne Pharma Commercial LLC2$26
Ironwood Pharmaceuticals, Inc1$24
Hikma Pharmaceuticals USA1$22
Seqirus USA Inc1$21
Antares Pharma, Inc.1$21
Actelion Pharmaceuticals US, Inc.1$20
Vyera Pharmaceuticals, LLC1$20
Upsher-smith Laboratories LLC1$18

How this compares

$12,970 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.

See all medical providers in North Carolina

Medicare billing

Part B allowed, 2024
$38,689
Medicare patients
165
Services billed
575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →